Results 201 to 210 of about 9,118,901 (248)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 1994
Combinations of drugs such as methotrexate, cyclosporin A, and prednisone have reduced the incidence of graft-versus-host disease (GVHD) to 20% to 30%. However, GVDH remains a major complication (up to 90%) following allogeneic bone marrow transplantation from unrelated or mismatched donors.
openaire +3 more sources
Combinations of drugs such as methotrexate, cyclosporin A, and prednisone have reduced the incidence of graft-versus-host disease (GVHD) to 20% to 30%. However, GVDH remains a major complication (up to 90%) following allogeneic bone marrow transplantation from unrelated or mismatched donors.
openaire +3 more sources
Journal of the American Academy of Dermatology, 1981
Graft versus host disease (GVHD) occurs in 50% to 70% of patients receiving bone marrow transplants. It can also develop in immunosuppressed patients with malignancies who receive nonirradiated blood transfusions. Most work indicates that the primary mechanism of GVHD is cell-mediated. It is likely that humoral factors are involved as well.
openaire +2 more sources
Graft versus host disease (GVHD) occurs in 50% to 70% of patients receiving bone marrow transplants. It can also develop in immunosuppressed patients with malignancies who receive nonirradiated blood transfusions. Most work indicates that the primary mechanism of GVHD is cell-mediated. It is likely that humoral factors are involved as well.
openaire +2 more sources
Chronic Graft-Versus-Host Disease
Oncology Nursing Forum, 2006Chronic graft versus host disease is a debilitating and often fatal complication of allogeneic stem cell transplantation. The purpose of this review is to overview this disease and highlight recent findings in the literature over the past year.A new focus on chronic graft versus host disease as a long-term complication of transplantation has resulted ...
Ellaine, Galbizo, Lori A, Williams
openaire +4 more sources
Ocular graft-versus-host disease
Current Opinion in Allergy & Clinical Immunology, 2012This review was carried out to study the frequency, and severity of ocular surface involvement at the setting of allogeneic hematopoietic stem cell transplantation and subsequent graft-versus-host disease (GVHD) and evaluate the clinical outcomes of newer treatments.Ocular involvement has been reported in 60-90% of patients with chronic GVHD.
Michelle, Hessen, Esen K, Akpek
openaire +2 more sources
Pathophysiology of Graft-Versus-Host Disease
Seminars in Hematology, 2006Complications of allogeneic hematopoietic stem cell transplantation (HSCT) remain barriers to its wider application for a variety of diseases. Graft-versus-host disease (GVHD) is the major cause of morbidity and mortality following allogeneic HSCT. GVHD can be considered an exaggerated, undesirable manifestation of a normal inflammatory mechanism, in ...
James L M, Ferrara, Pavan, Reddy
openaire +2 more sources
A review of graft versus host disease [PDF]
Children undergoing hematopoietic stem cell transplant often require intensive care support due to their underlying disease, sepsis, infection, hemorrhage, respiratory failure and organ dysfunction. The majority of children requiring intensive care support have an allogeneic donor.
Jerelyn R, Moffet +3 more
openaire +2 more sources
Chronic Graft-Versus-Host Disease
Journal of Hematotherapy & Stem Cell Research, 2000bidity following BMT is graft-versus-host disease (GVHD). In several large recent trials, 40‐ 60% of patients surviving more than 100 days have developed chronic GVHD (1‐ 3). The incidence of chronic GVHD is expected to rise due to several trends in transplantation.
J, Margolis, G, Vogelsang
openaire +2 more sources
Management of graft-versus-host disease
Transfusion Science, 1994Allogeneic bone marrow transplantation (BMT) involves transfer of primitive multipotential lymphohematopoietic stem cells from donor to recipient. In clinical transplantation, however, the aspirated marrow also contains substantial numbers of viable lymphoid cells, some originating from the marrow and some inadvertently collected by contamination of ...
openaire +2 more sources
Chronic graft-versus-host disease
Nature Reviews Disease PrimersChronic graft-versus-host disease (cGVHD) is a major complication of allogeneic haematopoietic cell transplantation. cGVHD has a heterogeneous biology and morbid manifestations, affecting 30-70% of recipients and substantially impairing quality of life and is the leading cause of non-relapse mortality in allo-HCT recipients.
Yishan Ye +7 more
openaire +2 more sources
Graft-versus-host disease and phimosis
Journal of Pediatric Urology, 2008Graft-versus-host disease rarely causes genitourinary problems. We report a case of pathological phimosis in a child secondary to chronic graft-versus-host disease.
S T, Patel +5 more
openaire +2 more sources

